In China, although the development of digital therapeutics is still in its early stages, it has attracted significant attention. In the capital market, digital therapeutics companies are also highly favored, with renowned institutions entering the field, later-stage financing rounds becoming common, and single-round funding exceeding RMB 100 million becoming the norm. Recently, Bositen Technology, which provides digital screening and training interventions for dementia, completed an A-round financing of RMB 100 million. Wangli Technology, which focuses on psychiatric digital therapeutics, has also secured tens of millions of yuan in funding.Weimai、Zhilan Health、Miao Health...and other companies have disclosed their moves in this field.
The Blue Ocean of Digital Therapeutics Has Emerged: How to Seize the First-Mover Advantage? As academics have stated, “We have already devoted considerable time to contemplating and theorizing about digital health and digital therapeutics; now is the time for action.”
ChinaThe First Digital Therapeutics Organization——The Digital Therapeutics Systems Engineering Professional Committee (Preparatory) of the China Association for Promotion of Rehabilitation Technology Translation and Development (hereinafter referred to as the “Professional Committee (Preparatory)”)Established and currently joined by enterprises/institutionsOver 60Home, all are stakeholders in the digital therapeutics value chain, including insurance payers, pharmaceutical and medical device companies, smart device manufacturers, digital therapeutics innovators, investment institutions, and more. The "Digital Therapeutics Industry Tour in China" is a key project in the annual plan of the Preparatory Committee for the Specialized Committee.June 25AtHangzhouConveneDigital Therapeutics City Summit, with planned invitations to clinical research scholars and investment firms,Digital Therapeutics Innovatoretc., focusing on key issues such as clinical applications, data, regulatory approval, use cases, and business models of digital therapeutics, to promote collaborative cooperation among stakeholders in the value chain of digital therapeutics.
This Urban Summit is hosted byDigital Therapeutics and Systems Engineering Professional Committee (Preparatory), China Association for Promotion of Rehabilitation Technology Translation and DevelopmentHosted by;VCBeat, Yuan Yi Capital, Takeda (China), Viatris, Weimai, Fosun Pharma, Sanofi (China),Zhilan HealthCo-hosted by;Tasly, Senmei Medical, Huanuo Zhisheng, Miao Health, Shukang, Yuanxin Technology, Rendong Medicine, Tigermed Jietong, Good Doctor Hui, Boston TechGu YitangCo-organizer;Yongliu Technology, Yunkai Yamei, ALSOLIFE, BlueRun VenturesSupport.
Digital Therapeutics Hangzhou City Summit
The City Summit adopts a free registration and review system; upon approval, participants may attend the event.
Proposed Agenda:
Time | Form | Proposed Agenda | Proposed Guests |
Host: Bi Yuanfeng | Co-founder and COO of VCBeat | |||
14:00-14:05 | Opening Remarks | Leader's Address | Yang Han | Deputy Secretary-General and Director of Strategic Development, China Association for the Promotion of Rehabilitation Technology Translation and Development |
14:05-14:35 | Video Call | "Clinical Practice of 'Digital Prescriptions' in the Diagnosis and Treatment of Chronic Diseases (Proposed)" | Hou Jinlin | Director and Professor, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University |
14:35-15:05 | Keynote Speech | An Analysis of the Development of Digital Therapeutics Companies in China and Abroad | Yang Ruirong | Partner, Yuanyi Capital |
15:05-15:35 | Keynote Address | Internet Plus Full-Course Disease Management and Digital Therapeutics | Ying Li | Vice President of Weimai, Medical CenterGeneral Manager |
15:35-16:05 | Keynote Address | Sharing Experience in the Approval of Digital Therapeutics | Wang Haiwei | Chief Operating Officer, Hangzhou Zhilan Health Co., Ltd. |
16:05-16:35 | Keynote Address | Exploration of Practical Applications of VR Technology in Digital Therapeutics | Cao Qun | Founder and Chairman of Xinjing Technology |
16:35-17:30 | Roundtable Discussion | Exploring the Value Realization Pathway of Digital Therapeutics | Host: Song Yiran | Investment Director, Yuanyi Capital Wan Ma | General Manager, Weimai AI Digital Therapeutics Center; Ph.D. Wang Haiwei | Chief Operating Officer, Hangzhou Zhilan Health Co., Ltd. Gao Yunlong | Founder and CEO of Huizhong Respiratory Liu Wenzhe | Founder and CEO of U-Brain Peng Yifei | General Manager, Tigermed Jietong |
Venue: Hangzhou (specific address to be notified upon approval of registration)
Registration Validity Period: June 15–June 24
Registration Link:http://hdxu.cn/WLNw2

(Limited spots available; register early)
By the National First-Class AssociationChina Association for the Promotion of Rehabilitation Technology Translation and Development、VCBeat、Yuan Yi CapitalThe First Formal Organization for Digital Therapeutics in China, Jointly Initiated by—Digital Therapeutics and Systems Engineering Professional Committee (Preparatory) of the China Association for Promotion of Rehabilitation Technology Translation and Development (hereinafter referred to as the “Professional Committee (Prep.)”),Voluntarily formed by clinical and research experts in the field of digital therapeutics in China, industry elites, professionals from technology management and technical testing sectors, clinical institutions, research institutes, and related enterprises, it serves as a vital force in the theoretical research and practical development of digital therapeutics systems engineering., the Preparatory Committee aims to:
Promote Industry Consensus: Based on Chinese practices, establish definitions, standards, and specifications for digital therapeutics that align with specific markets, thereby fostering industry consensus;
Promoting Practice in China: On the basis of adhering to relevant principles, explore pathways, identify cases, and create benchmarks to actively advance the practice of digital therapeutics in China;
Creating Value Through Collaboration: Guided by shared values and principles, we actively facilitate in-depth discussions and foster collaborative synergy among diverse stakeholders in the digital therapeutics ecosystem.
Establish a dialogue mechanism: Establish a dialogue mechanism with government regulatory authorities to facilitate full exchange on the progress and challenges in the field of digital therapeutics, and to convey the latest policy directions.
This year is expected toTwo Research Projects,2 Dialogue Regulatory Agency Projects ,Six In-Depth Industry Exchange Sessions on Different Themes, 1 annual conference project + N appearances. The annual work plan is as follows:
No. | Project Name | Form | Estimated Completion Time |
1 | 《China Digital Therapeutics White Paper 2021》 | Report | Mid-May 2021 |
2 | Special Topic Exchange on Clinical Practice of Digital Therapeutics—Functional Rehabilitation | City Mini Forum, Chongqing | Late May 2021, half a day |
3 | Special Topic Exchange on Clinical Practice of Digital Therapeutics—Brain Science | City Mini Forum, Hangzhou | June 2021, half a day |
4 | Special Topic Exchange on Clinical Practice of Digital Therapeutics—Chronic Disease Management | City Mini Forum, Nanjing (Shanghai) | July 2021, half a day |
5 | A Comparative Study of Digital Therapeutics Policies in China and the United States | Closed-door meeting, approximately 20 attendees, Beijing (or Shanghai) | July 2021, half a day |
6 | Special Discussion on Reimbursement for Digital Therapeutics | City Mini Forum, Shanghai | August 2021, Half a Day |
7 | Special Topic Exchange on Digital Therapeutics and Devices | City Mini Forum, Shenzhen | August 2021, Half a Day |
8 | Seminar on Policy Approval and Industry Practices for Digital Therapeutics | Closed-door meeting, approximately 20 attendees, Chengdu (or Suzhou) | Mid-September 2021, half a day |
9 | Special Topic Exchange on the Synergy Between Digital Therapeutics and Pharmaceutical Companies | City Mini Forum, Shanghai | Mid-October 2021, half a day |
10 | "China Digital Therapeutics Industry Development Report 2021" | Report | November–December 2021 |
11 | 2021 Digital Therapeutics Annual Conference | Large-scale forum, held independently or concurrently with related events, in Shanghai (or Suzhou) | December 2021, 1 day |
12 | Co-organize and jointly organize digital therapeutics-related activities | Co-branded Participation | Year-round |

(April 15, Suzhou: Preparatory Meeting for the Digital Therapeutics Systems Engineering Professional Committee of the China Association for Promotion of Rehabilitation Technology Translation and Development)

(April 16, Suzhou: The Digital Therapeutics Innovation Forum of the Future Healthcare Top 100 Conference was held)

(May 28, Chongqing: Study Tour to Senmei Medical, a Benchmark Enterprise in Digital Therapeutics, Held)

(May 28, Chongqing: The China Digital Therapeutics Industry Tour – Chongqing City Summit Held)
Contact: Fang Qiuxue
Tel: 15208495425

WeChat: Same as above (please add the note “Special Committee Inquiry” when adding)